787 results on '"Yoo, Keon Hee"'
Search Results
52. PPARδ Agonist Promotes Type II Cartilage Formation in a Rabbit Osteochondral Defect Model
53. Postchemotherapy gross residual tumor in non‐high‐risk neuroblastoma: Clinical significance and the role of adjuvant therapy
54. Pre-Engraftment Syndrome after Unrelated Cord Blood Transplantation: A Predictor of Engraftment and Acute Graft-versus-Host Disease
55. Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients
56. Invasive Hormographiella aspergillata Infection Identified Using DNA Sequencing
57. A Case of a 16-Year-Old Patient With Chronic Invasive Aspergillosis in the Trachea Treated With Segmental Tracheal Resection and Cricotracheal Anastomosis
58. Case Report: Novel Splicing Variant in SH2D1A in a Patient With X-Linked Lymphoproliferative Syndrome Type 1
59. Clinical Significance of Germline Telomere Length and Associated Genetic Factors in Patients with Neuroblastoma
60. Prospective Trial of Ibrutinib for the Treatment of Pediatric Chronic Graft-Versus-Host Disease
61. Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults
62. Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: A Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group
63. Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification
64. Clinical implication of residual MIBG‐positive disease in the follow‐up of high‐risk neuroblastoma treated with tandem high‐dose chemotherapy and autologous stem cell transplantation
65. Intensive chemotherapy followed by reduced-dose radiotherapy for biopsy-proven CNS germinoma with elevated beta-human chorionic gonadotropin
66. Congenital thrombotic thrombocytopenic purpura (Upshaw–Schulman syndrome) caused by novel ADAMTS13 mutations
67. Cell culture density affects the proliferation activity of human adipose tissue stem cells
68. A strategy for enhancing the engraftment of human hematopoietic stem cells in NOD/SCID mice
69. Successful Engraftment with Fludarabine, Cyclophosphamide, and Thymoglobulin Conditioning Regimen in Unrelated Transplantation for Severe Aplastic Anemia: A Phase II Prospective Multicenter Study
70. Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS): Interim Analysis
71. Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants
72. Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea
73. Correction to: Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center
74. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party
75. Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia
76. Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea
77. Epidemiology of Acute Leukemia among Children with Down Syndrome in Korea
78. A minimal dose of unmanipulated bone marrow infusion without conditioning for T-B+NK- severe combined immunodeficiency
79. A phase 2 study of nilotinib in pediatric patients with CML:Long-term update on growth retardation and safety
80. Tandem high-dose chemotherapy and autologous stem cell transplantation for anaplastic ependymoma in children younger than 3 years of age
81. Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia
82. Double umbilical cord blood transplantation for children and adolescents
83. Stem and progenitor cells in human umbilical cord blood
84. Expression of MET in alveolar soft part sarcoma
85. Unrelated donor cord blood transplantation for non-malignant disorders in children and adolescents
86. Engraftment Efficacy of Human Hematopoietic Stem Cells Transplanted into NOD/SCID Mice Using Two Methods: Intra-Bone Marrow Transplantation of Hematopoietic Stem Cells and Intravenous Co-Transplantation with Mesenchymal Stem Cells
87. Atypical basal ganglia germinoma presenting as cerebral hemiatrophy: diagnosis and follow-up with 11C-methionine positron emission tomography
88. Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients
89. Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation.
90. Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years
91. Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
92. Strategies to enhance graft performance in cord blood transplantation
93. Additional file 2 of Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
94. Additional file 1 of Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
95. Additional file 5 of Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
96. Additional file 3 of Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
97. Additional file 1 of Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT
98. Additional file 4 of Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
99. Additional file 6 of Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
100. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.